SIK inhibitor (Nimbus Therapeutics)

N/A

Report date: 2025/06/11 11:18:21
NME

Base Information

Drug NameSIK inhibitor (Nimbus Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSalt-inducible kinase 3 inhibitorsImmunomodulators
TargetsSalt-inducible kinase 3
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNimbus Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesNimbus Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A